Summary
The effects of a 3-week treatment with the nonsteroidal “antiestrogen” tamoxifen were determined on cortical and trabecular bone mass of the tibiae of growing male rats that had undergone unilateral sciatic neurotomy (USN). USN resulted in decreases in cortical area (−11.3%), cross-sectional area (−8.4%), and periosteal bone formation rate (−32.6%) in cortical bone, indicating that the disuse osteopenia results in a decrease in bone formation in cortical bone. USN significantly reduced the amount of trabecular bone in our metaphyseal sampling site (−75%), markedly increasing the amount of bone surface lined by osteoclasts (+65%) without affecting the surface lined by osteoblasts. These results suggest that trabecular bone disuse osteopenia is due, at least in part, to increased bone resorption. Tamoxifen treatment significantly reduced the loss of trabecular bone, restoring resorbing surface length to the control (sham-operated) animal levels. Tamoxifen treatment of sham-operated animals increased trabecular bone area and surface by 35.7% (±10.5) and 41.8% (±7.8), respectively, and reduced resorbing surface by 21.5% (±11.6) compared with sham-operated placebo-treated rats. Tamoxifen had no significant effect on cortical bone parameters in the sham-operated group. The results indicate that tamoxifen is able to reduce the trabecular bone loss that results from USN, but has no effect on cortical bone disuse osteopenia, or on trabecular bone formation. Moreover, tamoxifen treatment of control (intact) animals inhibited the normal levels of bone resorption occurring in these rapidly growing animals.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gillespie JA (1954) The nature of the bone changes associated with nerve injuries and disuse. J Bone Joint Surg 36B:464–473
Landry M, Fleisch H (1964) The influence of immobilization on bone formation as evaluated by osseous incorporation of tetracyclines. J Bone Joint Surg 46B:764–771
Lutwak L, Whedon GD, Lachance PA, Reid JM, Lipscomb HS (1969) Mineral electrolyte and nitrogen balance studies of the Gemini-VII fourteen day orbital space flight. J Clin Endocrinol Metab 29:1140–1156
Turner RT, Wakley GK, Hannon KS, Bell NH (1987) Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats. J Bone Min Res 2(5):449–456
Turner RT, Wakley GK, Hannon KS, Bell NH (1988) Ovariectomy increases osteoclast mediated resorption of trabecular bone, an effect which is prevented by tamoxifen treatment. Endocrinology 122(3):1146–1150
Branham WS, Sheehan DM, Zehr DR, Medlock KL, Nelson CJ, Ridlon E (1985) Inhibition of rat uterine gland genesis by tamoxifen. Endocrinology 117:2238–2248
Jordan VC, Phelps E, Lindgren JU (in press) Effects of antiestrogens on bone in castrated and intact female rats. Breast Cancer Res Treatment
Beal PT, Mirsa LK, Young RL, Spjut HJ, Evans HJ, Le-Blanc A (1984) Clomiphene protects against osteoporosis in the mature ovariectomized rat. Calcif Tissue Int 36:123–125
Souma JA, Marshall LD, Abdul-Karim RW (1972) The effect of cis and trans clomiphene citrate on the collagen content of fetal bone. Toxicol Appl Pharmacol 23:339–343
Barden HS, Mazess RB, Green G, Love R (1987) Bone loss with chemical menopause and use of tamoxifen in breast cancer (abstract) J Bone Min Res 2 (suppl 1):A492
Baylink DJ, Stauffer M, Wergedal JE, Rich C (1970) Formation and mineralization of bone in vitamin D deficient rats. J Clin Invest 49:1122–1134
Turner RT, Bell NH (1986) The effects of immobilization on bone histomorphometry in rats. J Bone Min Res 1(5):399–407
Thompson ER, Baylink DJ, Wergedal JE (1975) Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat. Endocrinology 97:283–289
Stewart PJ, Stern PH (1986) Effects of the antiestrogen tamoxifen and clomiphene on bone resorption in vitro. Endocrinology 118:125–131
Arnett R, Lindsay R, Dempster DW (1986) Effect of estrogen and antiestrogens on osteoclast activity in vitro (abstract) J Bone Min Res 1 (suppl 1):99
Roodman GD, Ibbotson KJ, MacDonald BR, Kuehl TJ, Mundy GR (1985) 1,25-dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow. Proc Natl Acad Sci USA 82:8213–8217
Wronski TJ, Lowry PL, Walsh CC, Ignaszewski LA (1985) Skeletal alterations in ovariectomized rats. Calcif Tissue Int 37:324–329
Osborne CK, Boldt DH, Clark GM, Trent JM (1983) Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 43:3583–3585
Daniel CP, Guskell SJ, Nicholson RJ (1984) The measurement of tamoxifen and its metabolites in the rat and relationship to the response of DMBA-induced mammary tumors. Eur J Cancer Clin Oncol 20:137–148
Jordan VC (1984) Biochemical pharmacology of antiestrogen action. Pharmacol Rev 36:245–276
Orimo H, Fujita T, Yoshikawa M, Hayano K, Sakurada T (1971) Effect of estrogen on immobilization osteoporosis in rat. Endocrinology 88:102–105
Lyman S, Jordan VC (1985) Metabolism of tamoxifen and its uterotrophic activity. Biochem Pharmacol 34:2787–2794
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wakley, G.K., Baum, B.L., Hannon, K.S. et al. The effects of tamoxifen on the osteopenia induced by sciatic neurotomy in the rat: A histomorphometric study. Calcif Tissue Int 43, 383–388 (1988). https://doi.org/10.1007/BF02553283
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02553283